EXTENDED TRIPLE INTRATHECAL CHEMOTHERAPY TRIAL FOR PREVENTION OF CNS RELAPSE IN GOOD-RISK AND POOR-RISK PATIENTS WITH B-PROGENITOR ACUTE LYMPHOBLASTIC-LEUKEMIA - A PEDIATRIC ONCOLOGY GROUP-STUDY

PULLEN J BOYETT J SHUSTER J CRIST W LAND V FRANKEL L IYER R BACKSTROM L VANEYS J HARRIS M RAVINDRANATH Y SULLIVAN M

J. Pullen et al., EXTENDED TRIPLE INTRATHECAL CHEMOTHERAPY TRIAL FOR PREVENTION OF CNS RELAPSE IN GOOD-RISK AND POOR-RISK PATIENTS WITH B-PROGENITOR ACUTE LYMPHOBLASTIC-LEUKEMIA - A PEDIATRIC ONCOLOGY GROUP-STUDY, Journal of clinical oncology, 11(5), 1993, pp. 839-849

61

Oncology

Journal of clinical oncology → ACNP

0732183X

11

5

1993

839 - 849

ISI

0732-183X(1993)11:5<839:ETICTF>2.0.ZU;2-5